CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 180 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,719 | -17.7% | 11,436 | +1.5% | 0.00% | 0.0% |
| Q2 2023 | $382,425 | -2.6% | 11,271 | +3.2% | 0.00% | -25.0% |
| Q1 2023 | $392,794 | -16.5% | 10,917 | +3.4% | 0.00% | -20.0% |
| Q4 2022 | $470,570 | +64.5% | 10,558 | +3.9% | 0.01% | +66.7% |
| Q3 2022 | $286,000 | +4.8% | 10,164 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $273,000 | -20.6% | 10,117 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $344,000 | -11.1% | 10,091 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $387,000 | -32.1% | 10,008 | -5.1% | 0.00% | -40.0% |
| Q3 2021 | $570,000 | +58.3% | 10,550 | -1.9% | 0.01% | +66.7% |
| Q2 2021 | $360,000 | +51.9% | 10,755 | -6.6% | 0.00% | +50.0% |
| Q1 2021 | $237,000 | +19.1% | 11,518 | +1.5% | 0.00% | 0.0% |
| Q4 2020 | $199,000 | – | 11,347 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |